PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
11.70%
Net income growth under 50% of MRVL's 244.65%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
-1.75%
Both reduce yoy D&A, with MRVL at -0.88%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-285.71%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
-4.08%
Negative yoy SBC while MRVL is 14.53%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
148.85%
Slight usage while MRVL is negative at -286.09%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
84.57%
AR growth while MRVL is negative at -52.82%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
9.59%
Some inventory rise while MRVL is negative at -199.24%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
100.00%
A yoy AP increase while MRVL is negative at -62.85%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
8100.00%
Some yoy usage while MRVL is negative at -97.27%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
No Data
No Data available this quarter, please select a different quarter.
134.52%
Operating cash flow growth above 1.5x MRVL's 11.63%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-39.93%
Both yoy lines negative, with MRVL at -8.75%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
1.63%
Purchases growth of 1.63% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-64.00%
We reduce yoy sales while MRVL is 20436.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
No Data
No Data available this quarter, please select a different quarter.
-424.51%
Both yoy lines negative, with MRVL at -5992.74%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
-18.00%
Both yoy lines negative, with MRVL at -33.48%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
20.00%
Buyback growth of 20.00% while MRVL is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.